Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GALLIUM NITRATE FOR THE TREATMENT OF MALIGNANT TUMORS, A PHASE I STUDY

NCT00002543 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT00002543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GALLIUM NITRATE FOR THE TREATMENT OF MALIGNANT TUMORS, A PHASE I STUDY
Lead sponsor
Medical College of Wisconsin
Phase
Phase 1
Overall status
Completed
Start date
February 28, 1995
Completion date
October 31, 2004
Enrollment
3 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, lymphoma, neuroblastoma, sarcoma, unspecified childhood solid tumor, protocol specific